MAPT and Alzheimer disease: Previous studies analyzing cerebrospinal fluid (CSF) neurodegeneration markers, namely, Aβ42, Aβ40, total tau, and phosphorylated tau, in CAA patients focused on comparison with patients with Alzheimer ́s disease or with healthy controls.5